NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Motilal Oswal Maintains 'BUY' Rating on Five Star Business Finance

Five-Star Business Finance (FIVESTAR) reported a decline in profit after tax (PAT) for the fourth quarter of fiscal year 2026 (4QFY26) by 4% year-over-year (YoY) and 3% quarter-over-quarter (QoQ) to INR2.7 billion, which aligns with expectations. The company's PAT for the fiscal year 2026 (FY26) grew approximately 2% YoY to INR11 billion.

The net interest income (NII) of Five-Star Business Finance grew approximately 10% YoY to INR6.1 billion, meeting expectations. Other income rose 22% YoY to INR306 million, also in line with expectations. Operating expenses (Opex) increased 21% YoY to INR2.3 billion, meeting expectations. Profit before provisions and tax (PPoP) rose approximately 5% YoY to INR4.2 billion, meeting expectations. For the fiscal year 2026 (FY26), PPoP grew 11% YoY to INR16.8 billion.

Credit costs for the company stood at INR604 million, meeting expectations. The annualized credit cost was approximately 1.55% (previous quarter: 1.5% and previous year: 0.75%).

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Key Highlights:

MetricQ4 FY26Q4 FY25YOY Change
PATINR 2.7bINR 2.8b-4%
NIIINR 6.1bINR 5.5b10%
Other IncomeINR 306mINR 251m22%
OpexINR 2.3bINR 1.9b21%
PPoPINR 4.2bINR 4b5%

The stock currently trades at 1.7x the estimated price-to-book value (P/BV) for fiscal year 2027 (FY27E). Motilal Oswal estimates Five-Star Business Finance to post a compound annual growth rate (CAGR) of approximately 21%/12% in assets under management (AUM)/PAT over fiscal years 2026-2028E, with return on assets (RoA) and return on equity (RoE) of 6.6/15% in fiscal year 2028E. The research firm maintains a 'BUY' rating on the stock with a revised target price of INR600, based on a price of 1.8x the estimated book value for March 2028 (Mar'28E BV).

Investor Takeaway

Maintain BUY with a revised TP of INR600.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.